Give Us a Call: (608) 782-7300

Health Library Explorer
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z A-Z Listings Contact Us
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Click a letter to see a list of conditions beginning with that letter.
Click 'Topic Index' to return to the index for the current topic.
Click 'Library Index' to return to the listing of all topics.

Blood Count May Offer Clues to Treatment of COVID-19: Study

FRIDAY, May 1, 2020 (HealthDay News) -- The severity of COVID-19 illness may be influenced by what researchers call "cytokine storms."

In a new study, investigators assessed 522 COVID-19 patients, aged 5 days to 97 years, who were admitted to two hospitals in Wuhan, China, in December and January. The study also included a "control group" of 40 healthy people.

Compared to the control group, 76% of COVID-19 patients had significantly lower levels of T cells -- a type of white blood cell that plays a crucial role in immune response against viral infections.

Patients admitted to the intensive care unit had much lower T cell counts than those who didn't require ICU care. Patients over age 60 had the lowest T cell counts, the findings showed.

And the T cells that did survive in COVID-19 patients were exhausted and unable to function at full capacity, the study authors said.

COVID-19 patients also had high levels of cytokines -- a protein that normally helps fight off infection. Too many cytokines can prompt an excessive inflammatory response called a "cytokine storm," which causes the proteins to attack healthy cells.

That suggests the new coronavirus does not attack T cells directly. Instead, it triggers the cytokine release, which results in the loss and exhaustion of T cells, according to the authors of the study published May 1 in the journal Frontiers in Immunology.

The study results provide new clues on how to treat COVID-19, the researchers said.

"We should pay more attention to T cell counts and their function, rather than respiratory function of patients," study author Dr. Yongwen Chen of Third Military Medical University in Chongqing, China, said in a journal news release.

Chen added that "more urgent, early intervention may be required in patients with low T lymphocyte counts."

In addition, he noted, future research should focus on pinpointing subgroups of T cells that may be most important in COVID-19, along with identifying drugs that boost T cell counts and functioning.

More information

The U.S. Centers for Disease Control and Prevention has more on COVID-19.

SOURCE: Frontiers in Immunology, news release, May 1, 2020

Copyright ©2020 HealthDay. All rights reserved.
Powered by StayWell
About StayWell | Terms of Use | Privacy Policy | Disclaimer